scispace - formally typeset
L

Linda M. Benson

Researcher at Mayo Clinic

Publications -  95
Citations -  3153

Linda M. Benson is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Mass spectrometry & Capillary electrophoresis. The author has an hindex of 32, co-authored 93 publications receiving 3023 citations. Previous affiliations of Linda M. Benson include Universidade Nova de Lisboa & University of Rochester.

Papers
More filters
Journal ArticleDOI

Iron-Dependent Self-Assembly of Recombinant Yeast Frataxin: Implications for Friedreich Ataxia

TL;DR: It is proposed that iron-dependent self-assembly of recombinant mYfh1p reflects a physiological role for frataxin in mitochondrial iron sequestration and bioavailability and is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals.
Journal ArticleDOI

Recombinant Mycobacterium tuberculosis KatG(S315T) Is a Competent Catalase-Peroxidase with Reduced Activity toward Isoniazid

TL;DR: It is demonstrated that KatG(S315T), as expressed in E. coli, is a competent catalase-peroxidase that exhibits a reduced ability to metabolize isoniazid, and high-performance liquid chromatography analysis showed that wild-type KatG was more efficient than KatG
Journal ArticleDOI

Preconcentration and microreaction technology on-line with capillary electrophoresis

TL;DR: In this article, the potential merits of analyte concentrator and membrane preconcentration technologies are discussed, and the future developments are discussed for analyte separation by capillary electrophoresis.
Journal ArticleDOI

Neelaredoxin, an Iron-binding Protein from the Syphilis Spirochete, Treponema pallidum, Is a Superoxide Reductase

TL;DR: This finding, the first description of a T. pallidum iron-binding protein, indicates that the syphilis spirochete copes with oxidative stress via a primitive mechanism, which, thus far, has not been described in pathogenic bacteria.
Journal ArticleDOI

The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin Reductase

TL;DR: It is reported that chaetocin is a competitive and selective substrate for the oxidative stress mitigation enzyme thioredoxin reductase-1 (TrxR1) with lower K(m) than the TrxR2 native substrate thiOREDoxin (TrX), thereby attenuating reduction of the critical downstream ROS remediation substrate Trx at achieved intracellular concentrations.